Literature DB >> 24070869

DJ-1 modulates aggregation and pathogenesis in models of Huntington's disease.

Muhammad U Sajjad1, Edward W Green, Leonor Miller-Fleming, Sarah Hands, Federico Herrera, Susanna Campesan, Ali Khoshnan, Tiago F Outeiro, Flaviano Giorgini, Andreas Wyttenbach.   

Abstract

The oxidation-sensitive chaperone protein DJ-1 has been implicated in several human disorders including cancer and neurodegenerative diseases. During neurodegeneration associated with protein misfolding, such as that observed in Alzheimer's disease and Huntington's disease (HD), both oxidative stress and protein chaperones have been shown to modulate disease pathways. Therefore, we set out to investigate whether DJ-1 plays a role in HD. We found that DJ-1 expression and its oxidation state are abnormally increased in the human HD brain, as well as in mouse and cell models of HD. Furthermore, overexpression of DJ-1 conferred protection in vivo against neurodegeneration in yeast and Drosophila. Importantly, the DJ-1 protein directly interacted with an expanded fragment of huntingtin Exon 1 (httEx1) in test tube experiments and in cell models and accelerated polyglutamine aggregation and toxicity in an oxidation-sensitive manner. Our findings clearly establish DJ-1 as a potential therapeutic target for HD and provide the basis for further studies into the role of DJ-1 in protein misfolding diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24070869     DOI: 10.1093/hmg/ddt466

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  19 in total

1.  Absence of DJ-1 causes age-related retinal abnormalities in association with increased oxidative stress.

Authors:  Vera L Bonilha; Brent A Bell; Mary E Rayborn; Ivy S Samuels; Anna King; Joe G Hollyfield; Chengsong Xie; Huaibin Cai
Journal:  Free Radic Biol Med       Date:  2017-01-11       Impact factor: 7.376

2.  α-Synuclein modifies mutant huntingtin aggregation and neurotoxicity in Drosophila.

Authors:  Gonçalo M Poças; Joana Branco-Santos; Federico Herrera; Tiago Fleming Outeiro; Pedro M Domingos
Journal:  Hum Mol Genet       Date:  2014-12-01       Impact factor: 6.150

3.  The small heat shock protein Hsp31 cooperates with Hsp104 to modulate Sup35 prion aggregation.

Authors:  Kiran Aslam; Chai-Jui Tsai; Tony R Hazbun
Journal:  Prion       Date:  2016-11       Impact factor: 3.931

4.  Novel proteomic changes in brain mitochondria provide insights into mitochondrial dysfunction in mouse models of Huntington's disease.

Authors:  Sonal Agrawal; Jonathan H Fox
Journal:  Mitochondrion       Date:  2019-03-20       Impact factor: 4.160

5.  DJ1 represses glycolysis and cell proliferation by transcriptionally up-regulating Pink1.

Authors:  Raquel Requejo-Aguilar; Irene Lopez-Fabuel; Daniel Jimenez-Blasco; Emilio Fernandez; Angeles Almeida; Juan P Bolaños
Journal:  Biochem J       Date:  2015-04-15       Impact factor: 3.857

6.  The transrepression arm of glucocorticoid receptor signaling is protective in mutant huntingtin-mediated neurodegeneration.

Authors:  S Varadarajan; C Breda; J L Smalley; M Butterworth; S N Farrow; F Giorgini; G M Cohen
Journal:  Cell Death Differ       Date:  2015-02-06       Impact factor: 15.828

7.  Bis-isatin derivatives: design, synthesis, and biological activity evaluation as potent dimeric DJ-1 inhibitors.

Authors:  Xiao-Bing Chen; Hai-Ying Zhu; Kun Bao; Li Jiang; Hong Zhu; Mei-Dan Ying; Qiao-Jun He; Bo Yang; Rong Sheng; Ji Cao
Journal:  Acta Pharmacol Sin       Date:  2021-01-25       Impact factor: 7.169

8.  Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntington's disease.

Authors:  Angelica Vittori; Carlo Breda; Mariaelena Repici; Michael Orth; Raymund A C Roos; Tiago F Outeiro; Flaviano Giorgini; Edward J Hollox
Journal:  Hum Mol Genet       Date:  2014-01-22       Impact factor: 6.150

9.  Glycation potentiates neurodegeneration in models of Huntington's disease.

Authors:  Hugo Vicente Miranda; Marcos António Gomes; Joana Branco-Santos; Carlo Breda; Diana F Lázaro; Luísa Vaqueiro Lopes; Federico Herrera; Flaviano Giorgini; Tiago Fleming Outeiro
Journal:  Sci Rep       Date:  2016-11-18       Impact factor: 4.379

10.  DJ-1 interactions with α-synuclein attenuate aggregation and cellular toxicity in models of Parkinson's disease.

Authors:  L Zondler; L Miller-Fleming; M Repici; S Gonçalves; S Tenreiro; R Rosado-Ramos; C Betzer; K R Straatman; P H Jensen; F Giorgini; T F Outeiro
Journal:  Cell Death Dis       Date:  2014-07-24       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.